The Severity and Atypical Presentations of COVID-19 Infection in Pediatrics
Overview
Authors
Affiliations
Background: Emergence of 2019-nCoV attracted global attention and WHO declared COVID-19 a public health emergency of international concern. Therefore we aimed to explore the severity and atypical manifestations of COVID-19 among children.
Methods: This is an observational cohort study conducted on 398 children with confirmed COVID-19 by using real-time reverse transcriptase polymerase chain reaction assay for detection of 2019-nCoV nucleic acid during the period from March to November 2020. Patients were subdivided regarding the severity of COVID-19 presentation into Group I (Non-severe COVID-19) was admitted into wards and Group II (Severe COVID-19) admitted into the PICU.
Results: Non- severe cases were 295cases (74.1%) and 103cases (25.9%) of severe cases. There was a significant difference between age groups of the affected children (P < 0.001) with a median (0-15 years). Boys (52%) are more affected than girls (48%) with significant differences (P < 0.001). 68.6%of confirmed cases had contact history to family members infected with COVID-19. 41.7% of severe patients needed mechanical ventilation. Death of 20.4% of severe cases. In COVID-19 patients, fever, headache, fatigue and shock were the most prominent presentations (95, 60.3, 57.8, and 21.8% respectively). 3.5% of children were manifested with atypical presentations; 1.25% manifested by pictures of acute pancreatitis, 1.25% presented by manifestations of deep venous thrombosis and 1.0% had multisystem inflammatory syndrome (MIS-C). Multivariate regression analysis showed that COVID-19 severity in children was significantly higher among children with higher levels of D-dimer, hypoxia, shock and mechanical ventilation.
Conclusion: Most children had a non-severe type of COVID-19 and children with severe type had higher levels of D-dimer, hypoxia, shock and mechanical ventilation.
Kulkarni D, Ismail N, Zhu F, Wang X, Del Carmen Morales G, Srivastava A J Glob Health. 2024; 14:05003.
PMID: 38419461 PMC: 10902805. DOI: 10.7189/jogh.14.05003.
D-dimer Levels in Predicting Severity of Infection and Outcome in Patients with COVID-19.
Esmailian M, Vakili Z, Nasr-Esfahani M, Heydari F, Masoumi B Tanaffos. 2023; 21(4):419-433.
PMID: 37583776 PMC: 10423863.
COVID-19 and Thromboembolic Events in the Pandemic and Pre-Pandemic Era: A Pediatric Cohort.
Rubino C, Bechini C, Stinco M, Lasagni D, Indolfi G, Trapani S Viruses. 2023; 15(7).
PMID: 37515240 PMC: 10383326. DOI: 10.3390/v15071554.
Allen A, Kudenchak L Cureus. 2023; 15(6):e40564.
PMID: 37465797 PMC: 10351913. DOI: 10.7759/cureus.40564.
COVID-19 and liver dysfunction in children: Current views and new hypotheses.
Yun Y, Feng Z, Zhang J World J Hepatol. 2023; 15(3):353-363.
PMID: 37034238 PMC: 10075013. DOI: 10.4254/wjh.v15.i3.353.